Results 41 to 50 of about 5,551,076 (177)
An Approach to Pneumonia in Immunocompetent Patients
Pneumonia is a leading cause of morbidity. Pneumonia is defined as a lung inflammation of infectious etiology. It can be subcategorized into Community Acquired Pneumonia, Hospital Acquired Pneumonia and Ventilator Acquired Pneumonia.
Spandana Veeravalli, Safiya Soullane
doaj +1 more source
Aim. Сommunity-acquired pneumonia is life-threatening disease with level of fatal events in hospitals within 12-36 %. In turn, presence of congestive heart failure or type 2 diabetes increases the risk of adverse outcomes in patients with community ...
O. S. Makharynska +2 more
doaj +1 more source
Hospital management of community-acquired pneumonia in Malta [PDF]
Community-acquired pneumonia (CAP) remains a common diagnosis requiring hospital admission and a leading cause of death worldwide. No local guideline is currently available for the management of CAP.
Mamo, Jonathan +3 more
core
A Clinical Comparative Study of Piperacillin and Sulbactam/Ampicillin in Patients with Community-Acquired Bacterial Pneumonia [PDF]
Objective To evaluate the clinical usefulness of piperacillin (4 g/day) therapy for community-acquired pneumonia compared to sulbactam/ampicillin (6 g/day).
Higashiyama, Yasuhito +10 more
core +1 more source
Community acquired pneumonia [PDF]
La pneumonie acquise est une maladie commune chez l'adulte due a certains pathogenes. Le diagnostic de la maladie se fait essentiellement par des tests hematologiques et biochimiques et le traitement est a base d'antibiotiques de la classe des ...
openaire +2 more sources
Extensive research has established that community acquired pneumonia has negative impact on clinical course on coronary heart disease (CHD), but the pathogenic mechanism was not understood. Aim. To study the pro-inflammatory biomarkers and endothelial
N. S. Mykhailovska , T. O. Kulynych
doaj +1 more source
A Worldwide Perspective of Atypical Pathogens in Community-Acquired Pneumonia
Rationale: Controversy still exists in the international literature regarding the need to use antimicrobials covering atypical pathogens when initially treating hospitalized patients with community-acquired pneumonia (CAP).
T. J. Marrie +14 more
core +1 more source
Increasing Pneumocystis pneumonia, England, UK, 2000-2010. [PDF]
After an increase in the number of reported cases of Pneumocystis jirovecii pneumonia in England, we investigated data from 2000-2010 to verify the increase. We analyzed national databases for microbiological and clinical diagnoses of P.
Nichols, Gordon +13 more
core +1 more source
Effect of vaccination on morbidity and mortality from community-acquired pneumonia
Background. Community-acquired pneumonia remains one of the most common and life-threatening forms of pathology among respiratory diseases.The aim of the study. To identify the features of the epidemiology of communityacquired pneumonia in the conditions
T. A. Bayanova +2 more
doaj +1 more source
Advances in community-acquired pneumonia
Community-acquired pneumonia is one of the commonest and deadliest of the infectious diseases, yet our understanding of it remains relatively poor. The recently published American Thoracic Society and Infectious Diseases Society of America Community ...
Barbara Jones, Grant Waterer
doaj +1 more source

